ZTS250117P170000
- 3.80
- 0.000.00%
Zoetis Newsroom
Animal Gastroesophageal Reflux Disease Market Analysis Report 2025-2030, With Profiles of Key Players Zoetis, Merck, Elanco, Ceva, BioZyme, Annamaet Petfoods, Hill's Pet Nutrition, Blue Buffalo & More
Wall Street Today: S&P 500 Closes at Record, Trump Keeps Appearing on TV
Live Stock News: Market Waiting to See if the President Says Something Exciting Today
Wall Street Today: Does Anyone Have the Cash for Stargates
Live Stock: Stargate Rivals the Scale of the Manhattan Project, Musk Said it's a Pipe Dream
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Fund Update: Stonehage Fleming Financial Services Holdings Ltd Just Disclosed New Holdings
Wall Street Today: AI Domestic Investment News on the Way
Live Stock News: Market Climbs, Crypto Falls, Big Tech is Here and Trump Starts Signing Orders
Zoetis Inc. (NYSE:ZTS) Delivered A Better ROE Than Its Industry
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Leerink Partners Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $205
Zoetis To Go Ex-Dividend On January 21st, 2025 With 0.5 USD Dividend Per Share
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Fund Update: Sarasin & Partners LLP Just Disclosed New Holdings
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
Express News | Zoetis Inc : Leerink Partners Cuts Target Price to $205 From $215